11051-71-1 (阿维霉素,Avilamycin (~80%))

阿维霉素;卑霉素;阿拉维霉素;阿维拉霉素;

Avilamycin;Avilomycin;Avilamycine;NS00126620;Avilamycina (INN-Spanish);Avilamycin [USAN:INN:BAN];Surmax;HSDB 7029;Avilamycinum (INN-Latin);LY-048740;Avilamycinum [INN-Latin];DTXSID40891398;avilamicina;Avilamycinum (Latin);POLYETHER ANTIBIOTIC COMPLEX PRODUCED BY STREPTOMYCES VIRIDOCHROMOGENES ETH 23575;Avilamycine [INN-French];720WDX56D3;DTXCID701030518;UNII-720WDX56D3;Avilamycinum;11051-71-1;Avilamycine (INN-French);Inteprity;Kavault;Avilamycina [INN-Spanish];Avilamycina;LY 048740;LY 048 740;DB11375;

PJSLUJVRJULESG-TUFPWFENSA-N

InChI=1S/C61H88Cl2O32.ClH/c1-21(2)53(70)87-49-45-32(92-61(93-45)52-51(78-20-79-52)60(72,27(8)64)28(9)91-61)19-77-56(49)89-57-48(76-14)39(68)44(31(83-57)18-73-11)88-55-40(69)47(43(74-12)24(5)82-55)85-34-17-58(10)50(26(7)81-34)94-59(95-58)16-30(66)42(25(6)90-59)84-33-15-29(65)41(23(4)80-33)86-54(71)35-22(3)36(62)38(67)37(63)46(35)75-13;/h21,23-26,28-34,39-45,47-52,55-57,65-69,72H,15-20H2,1-14H3;1H/t23-,24-,25-,26-,28-,29-,30-,31-,32+,33+,34+,39+,40-,41-,42-,43+,44-,45-,47-,48+,49-,50-,51-,52-,55+,56?,57+,58-,59?,60+,61-;/m1./s1

[C@@H]12OCO[C@H]1[C@](O)(C(C)=O)[C@@H](C)O[C@]12O[C@H]2COC([C@@H]([C@@H]2O1)OC(=O)C(C)C)O[C@@H]1O[C@H](COC)[C@H]([C@H](O)[C@@H]1OC)O[C@@H]1O[C@@H]([C@H](OC)[C@@H]([C@H]1O)O[C@@H]1O[C@H](C)[C@@]2([H])OC3(O[C@]2(C)C1)C[C@@H](O)[C@H](O[C@H]1C[C@@H](O)[C@H](OC(C2=C(C(=C(O)C(Cl)=C2OC)Cl)C)=O)[C@@H](C)O1)[C@@H](C)O3)C.Cl